"Licensing board or commission." An administrative board or
commission under the Bureau of Occupational and Professional
Affairs in the Department of State.
"Pharmacist." As defined in section 2(10) of the act of
September 27, 1961 (P.L.1700, No.699), known as the Pharmacy
Act.
"Prescriber." A person who is licensed, registered or
otherwise lawfully authorized to prescribe a controlled
substance or any other drug or device in the course of
professional practice or research in this Commonwealth.
Section 3. Drugs for off-label use to treat coronavirus
infections causing respiratory-syndrome-related
illnesses.
(a) Authorization.--A prescriber may prescribe, and a
pharmacist shall dispense, in accordance with a prescription
drug order and with the informed consent of a patient, a
therapeutic drug approved by the United States Food and Drug
Administration, including hydroxychloroquine sulfate and
ivermectin, for off-label use to the patient for prophylaxis or
for at-home, early-stage outpatient or hospital inpatient
treatment of coronavirus infections causing respiratory-
syndrome-related illnesses.
(b) Exposure not required.--A patient's suspected exposure
to coronavirus infections causing respiratory-syndrome-related
illnesses shall not be required for a prescriber to prescribe,
and a pharmacist to dispense, a drug to the patient for
prophylaxis as authorized under subsection (a).
(c) Screening not required.--A patient's positive screening
results test shall not be required for a prescriber to
prescribe, and a pharmacist to dispense, a drug to the patient
20210HB1741PN1972 - 2 -
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30